ACORDA THERAPEUTICS (NASDAQ:ACOR)

29.99

+0.07 (0.23%)

ACORDA THERAPEUTICS (NASDAQ:ACOR) Delayed :
Previous Close	$29.92	52 Week High	$31.78
Open	$30.18	52 Week Low	$15.52
Day High	$30.43	P/E	N/A
Day Low	$29.94	EPS	$-2.17
Volume	954,133
More ACOR Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
ELN	9	BIIB	5
AMLN	4	ALTH	4
SLTM	3	LNC	2
KCP	2	CXM	2
BKD	2	HGSI	2
CAGC	2	MDVN	2

View All Entities

Nov 3, 2009 07:56 AM Acorda Thera (ACOR) Posts Q3 Loss of $0.51, 8c Better than Estimates
Oct 15, 2009 06:32 AM FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
Jul 1, 2009 07:22 AM Acorda (ACOR) Enters License Agreement With Biogen Idec (BIIB) For Fampridine-SR Outside the U.S.

Feb 5, 2010 09:31 AM Hapoalim Securities Reiterates a 'Buy' on Acorda (ACOR); Premium Ampyra Pricing
Feb 4, 2010 07:27 AM Baird Downgrades Acorda Therapeutics (ACOR) to Neutral; Valuation Call
Feb 3, 2010 07:52 AM Acorda Therapeutics (ACOR) Prices AMPYRA Walking Treatment in MS Patients
Feb 2, 2010 07:53 AM J.P. Morgan Maintains an 'Overweight' on Acorda Therapeutics (ACOR), Adds to Focus List
Jan 25, 2010 11:54 AM Acorda's (ACOR) MS Drug Gets Nod From the FDA

Feb 3, 2010 07:00AM Acorda Therapeutics to Present at the 12th Annual BIO CEO & Investor Conference
Feb 3, 2010 06:00AM Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA(TM) (dalfampridine)
Jan 25, 2010 07:00AM Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Jan 25, 2010 02:00AM Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets
Jan 25, 2010 02:00AM Elan Drug Technologies Welcomes the NDA Approval of MS Drug AMPYRA(TM) (Dalfampridine) Extended Release Tablets

Feb 8, 2010 04:07 AM Wild Weekly Wrap-Up: Everyone Just Relax
Jan 28, 2010 11:23 AM Acorda Should Reap Rewards for MS Drug Ampyra
Jan 27, 2010 05:57 AM Acorda's MS Drug May Not Be the Windfall Investors Expect
Jan 26, 2010 09:47 AM Tightening Tuesday: Global Edition
Jan 26, 2010 03:55 AM Acorda MS Drug Gets FDA Clearance

Feb 3, 2010 03:57PM Form 4 ACORDA THERAPEUTICS INC For: Feb 02 Filed by: LAWRENCE DAVID
Feb 3, 2010 03:56PM Form 4 ACORDA THERAPEUTICS INC For: Feb 02 Filed by: Blight Andrew
Feb 3, 2010 06:16AM Form 8-K ACORDA THERAPEUTICS INC For: Feb 03
Jan 29, 2010 02:11PM Form SC 13G ACORDA THERAPEUTICS INC Filed by: BlackRock Inc.
Jan 29, 2010 06:16AM Form 8-K ACORDA THERAPEUTICS INC For: Jan 29

LOU KUEBLER
on Dec 18, 2009
at 08:27 AM I HAVE PPMS I HAVE TRIRD JUST ABOUT EVERYTHING. CHEMO IS NEXT. THIS SOUNDS TOO GOOD TO BE TRUE. PLEASE PASS IT.
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
ANDREW OLIVER SATCHELL
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
Naj Alikhan
on Nov 6, 2009
at 09:06 AM famridene Very exciting news. I have PPMS. When will it be available in the UK?
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
Naj Alikhan
on Nov 6, 2009
at 09:06 AM famridene Very exciting news. I have PPMS. When will it be available in the UK?
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
Judith A. Schlining
on Nov 3, 2009
at 11:02 AM Famridene I am 63 yrs old and have had MS sincew I was in my twenty's. Walking has become very hard for me due to fatigue and pain. Will fsmridene help e to have a more active life. I would love to play with my Grandchildren or go shopping.
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS

View All Comments

No comments are currently available.